Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Panying Mao"'
Publikováno v:
Annals of palliative medicine. 9(2)
BACKGROUND Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune and cyclophosphamide (CYC) is often used in the therapy of SLE. Anti-Mullerian hormone (AMH) is expressed in the ovarian granulosa cells and is a reliable biomarker for
Publikováno v:
Lupus. 27(13)
Introduction Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, the pathogenesis of which remains elusive. The deficiency or excess of thyroid hormone is defined as thyroid dysfunction, including (subclinical) hypothyroidism and (sub
Autor:
Shi Hong, Donghong Liu, Feng Lin, Wanwan Luo, Zhencheng Zhang, Panying Mao, Yan Liang, Zaixing Yang, Renqian Zhong
Publikováno v:
International immunopharmacology. 67
BACKGROUND CCL11, CCL24 and CCL26 are potent chemokines for eosinophils. Since there has been no study reporting the association serum CCL11, CCL24 and CCL26 with fibrotic progression of PBC, the aim of this study is to explore the association. METHO
Autor:
Wanwan Luo, Zaixing Yang, Renqian Zhong, Panying Mao, Yan Liang, Jing Xie, Yingpeng Ren, Feng Lin, Zhencheng Zhang
Publikováno v:
International immunopharmacology. 60
It has been demonstrated that serum human epididymis protein 4 (HE4) is a useful biomarker for differentiating lupus nephritis (LN) from systemic lupus erythematosus (SLE). However, it remains unclear whether HE4 can be used to predict the developmen